Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a re... von Giles, F J, Mauro, M J, Hong, F, Ortmann, C-E, McNeill, C, Woodman, R C, Hochhaus, A, le Coutre, P D, Saglio, G

Volltext

MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure von Agrawal, M, Hanfstein, B, Erben, P, Wolf, D, Ernst, T, Fabarius, A, Saussele, S, Purkayastha, D, Woodman, R C, Hofmann, W-K, Hehlmann, R, Hochhaus, A, Müller, M C

Volltext

Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance von Jabbour, E, le Coutre, P D, Cortes, J, Giles, F, Bhalla, K N, Pinilla-Ibarz, J, Larson, R A, Gattermann, N, Ottmann, O G, Hochhaus, A, Hughes, T P, Saglio, G, Radich, J P, Kim, D-W, Martinelli, G, Reynolds, J, Woodman, R C, Baccarani, M, Kantarjian, H M

Volltext

S839 PHASE II STUDY OF ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (MDS) von Navada, S.C., Garcia‐Manero, G., Atallah, E., Rajeh, M.N., Shammo, J.M., Griffiths, E.A., Khaled, S.K., Dakhil, S.R., Young, D.E., Odchimar‐Reissig, R., Demakos, E.P., Alvarado Valero, Y., Ohanian, M.N., Pemmaraju, N., John, R.B., Zbyszewski, P.S., Maniar, M., Petrone, M.E., Woodman, R.C., Fruchtman, S.M., Silverman, L.R.

Volltext

Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA) von Selak, S, Woodman, R.C, Fritzler, M.J

Volltext

Identification of New Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS) and Eosinophilia von Aspinall, A.I, Pinto, A, Auer, I.A, Bridges, P, Luider, J, Dimnik, L, Patel, K.D, Jorgenson, K, Woodman, R.C

Volltext

Anergy and acquired immune deficiency syndrome von Hegde, H.R., Woodman, R.C., Robbins, S.M.

Volltext

Epithelial cytoprotection by nitric oxide (NO) donors: Evidence for reduced superoxide (O 2)-mediated injury von Woodman, R.C., Gaboury, J., Kubes, P.

Volltext

Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease von Russell, J.A., Poon, M-C., Jones, A.R., Woodman, R.C., Ruether, B.A.

Volltext

Pulmonary function tests abnormalities in ulcerative colitis subjects von Godet, P.G., Cowie, R., Woodman, R.C., Sutherland, L.R.

Volltext

A Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors von Imbert, Paul RC, Louche, Arthur, Luizet, Jean‐Baptiste, Grandjean, Teddy, Bigot, Sarah, Wood, Thomas E, Gagné, Stéphanie, Blanco, Amandine, Wunderley, Lydia, Terradot, Laurent, Woodman, Philip, Garvis, Steve, Filloux, Alain, Guery, Benoit, Salcedo, Suzana P

Volltext